Cancer Family
Peritoneal Mesothelial Neoplasm
CI-CAN-00000317Explore in graph →
Non-malignant11 active trials2 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000317Explore in graph →
Clinical trials
27 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05193006 | Assessment of Histologic Prognostic Factors in Peritoneal Malignant Mesothelioma | unknown | — | 300 | Hospices Civils de LyonOTHER | 6 | Jan 14, 2022 | clinicaltrials |
| NCT02834169 | French National Registry of Rare Peritoneal Surface Malignancies(RENAPE) | unknown | — | 2,171 | Hospices Civils de LyonOTHER | 1 | Aug 22, 2017 | clinicaltrials |
| NCT02588131 | A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1) | unknown | Phase 2 | 40 | Italian Network for Tumor Biotherapy FoundationOTHER | 1 | Oct 27, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Jan 14, 2022source: clinicaltrials